Search results
Query: journal id: "aids"
previous
211 to 220 of 373
1
11
21
31
41
51
61
71
81
91
101
111
121
131
141
151
161
171
181
191
201
211
221
231
241
251
261
271
281
291
301
311
321
331
341
351
361
371
| 211 |  | Article: Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine E.H. Gisolf, R.H. Enting, S. Jurriaans, F. de Wolf, M.E. van der Ende, R.M.W. Hoetelmans, P. Portegies, S.A. Danner in: AIDS, Vol. 14 (2000), p. 1583-1589 |
| 212 | | Article: Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine E.H. Gisolf, R.H. Enting, S. Jurriaans, F. de Wolf, M.E. van der Ende, R.M.W. Hoetelmans, P. Portegies, S.A. Danner in: AIDS, Vol. 14 (2000), p. 1583-1589 |
| 213 | | Article: Decreased exposure to saquinavir in HIV-1-infected patients after long-term antiretroviral therapy including ritonavir and saquinavir E.H. Gisolf, R.P.G. van Heeswijk, R.M.W. Hoetelmans, S.A. Danner in: AIDS, Vol. 14 (2000), p. 801-805 |
| 214 | | Article: The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine E.H. Gisolf, S. Jurriaans, J. Pelgrom, F. van Wanzeele, M.E. van der Ende, K. Brinkman, M-J. Borst, F. de Wolf, A.J. Japour, S.A. Danner in: AIDS, Vol. 14 (2000), p. 405-413 |
| 215 | | Article: The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine E.H. Gisolf, S. Jurriaans, J. Pelgrom, F. van Wanzeele, M.E. van der Ende, K. Brinkman, M-J. Borst, F. de Wolf, A.J. Japour, S.A. Danner in: AIDS, Vol. 14 (2000), p. 405-413 |
| 216 | | Article: Highly active antiretroviral therapy including protease inhibitors does not confer a unique CD4 cell benefit: the AVANTI and INCAS study groups R. Harrigan, : Study group members AMC, P. Reiss, J.M.A. Lange in: AIDS, Vol. 14 (2000), p. 1383-1388 |
| 217 | | Article: Once-daily dosing saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study R.P.G. van Heeswijk, A.I. Veldkamp, J.W. Mulder, P.L. Meenhorst, J.M.A. Lange, J.H. Beijnen, R.M.W. Hoetelmans in: AIDS, Vol. 14 (2000), p. F103-F110 |
| 218 | | Article: The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals R.P.G. van Heeswijk, A.I. Veldkamp, J.W. Mulder, P.L. Meenhorst, F.W.N.M. Wit, J.M.A. Lange, S.A. Danner, N.A. Foudraine, M.O. Kwakkelstein, P. Reiss, J.H. Beijnen, R.M.W. Hoetelmans in: AIDS, Vol. 14 (2000), p. F77-F82 |
| 219 | | Article: Ritonavir-induced Cushing's syndrome in a patient treated with nasal fluticasone: letter M.E. Hillebrand-Haverkort, M.F. Prummel, J.H. ten Veen in: AIDS, Vol. 14 (2000), p. 1803-1803 |
| 220 | | Article: Normalization of the CD4 T cell receptor repertoire after evolution of syncytium-inducing HIV-1 variants: letter S. Kostense, E. Krop, H. Blaak, H. Schuitemaker, F. Miedema in: AIDS, Vol. 14 (2000), p. 330-331 |